Evidence-Based GI: An ACG Publication and Podcast
Ein Podcast von American College of Gastroenterology - Mittwochs
138 Folgen
-
Free Online Program Improves Adenoma Detection Rate and Decreases Post-Colonoscopy Colorectal Cancer
Vom: 14.6.2023 -
Prophylactic Antibiotics Do Not Improve Mortality in Severe Alcoholic Hepatitis Treated with Corticosteroids
Vom: 17.5.2023 -
Over-the-Scope Clips Decrease Non-Variceal Upper GI Bleeding vs Standard Endoscopic Treatment… In the Right Patient
Vom: 17.5.2023 -
Disposable Elevator Caps for Duodenoscopes Decrease Persistent Bacterial Contamination Without Hindering Technical ERCP Performance: The ICECAP Trial
Vom: 17.5.2023 -
ICYMI: Can we prevent hepatic decompensation? Most likely, with nonselective beta blockers.
Vom: 19.4.2023 -
Vibrating Capsules for Chronic Constipation: The New Non-Pharmacologic Approach
Vom: 19.4.2023 -
ICYMI: Vedolizumab Is Superior to Adalimumab for Clinical Remission and Endoscopic Improvement of Ulcerative Colitis-The VARSITY RCT
Vom: 19.4.2023 -
SEAVUE: a Sea of Change in Biologic Positioning for Crohn’s Disease
Vom: 19.4.2023 -
What are the Causes of Post-colonoscopy Colorectal Cancer?
Vom: 15.3.2023 -
Cold Snare Decreases Post-Polypectomy Bleeding vs Hot Snare for Small Polyps
Vom: 15.3.2023 -
Tumor-based screening for Lynch Syndrome: Check Every Colorectal Cancer
Vom: 15.3.2023 -
10-Year Intervals After Normal Screening Colonoscopy: It’s Not Too Long with High-Quality Colonoscopy
Vom: 15.3.2023 -
Dupilumab, an IgG4 Monoclonal Antibody, for Eosinophilic Esophagitis: Revising the Treatment Paradigm
Vom: 22.2.2023 -
Endoscopic Sleeve Gastroplasty Is Effective for Patients with Obesity Who MERIT Intervention
Vom: 22.2.2023 -
Early Colonoscopy for Acute Lower GI Bleeding Usually Is Not the Answer
Vom: 22.2.2023 -
Direct-Acting Antiviral Therapy for Hepatitis C Virus Decreases All-Cause Mortality and Decompensated Cirrhosis: Treat (Virtually) Everyone
Vom: 22.2.2023 -
ICYMI: Is Terlipressin for the Treatment of Hepato-Renal Syndrome Ready for Primetime: Results of the CONFIRM Trial
Vom: 3.2.2023 -
Risankizumab, an Interleukin-23 Inhibitor, for Moderate-Severe Crohn’s Disease: Advancing Care Beyond Anti-TNF Therapy
Vom: 25.1.2023 -
Risankizumab, an Interleukin-23 Inhibitor, for Moderate-Severe Crohn’s Disease: Advancing Care Beyond Anti-TNF Therapy
Vom: 25.1.2023 -
When It’s Not Acid Reflux: Managing PPI-Resistant GERD Patients Based on Bravo Results
Vom: 25.1.2023
A new monthly publication from the American College of Gastroenterology, Evidence-Based GI (EBGI) uses evidence-based methods to create abstracts and explain study results of new and important articles in the field of gastroenterology and hepatology. Listen as editors of EBGI discuss the articles they review and how the recommendations can be applied to your practice.
